摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

2-(R)-hydroxy-2-methyl-1-(4-(methylsulfonyl)phenyl)-4.4,4-trifluoro-1-butanone | 189956-23-8

中文名称
——
中文别名
——
英文名称
2-(R)-hydroxy-2-methyl-1-(4-(methylsulfonyl)phenyl)-4.4,4-trifluoro-1-butanone
英文别名
2-(R)-hydroxy-2-methyl-1-(4-(methylsulfonyl)phenyl)-4,4,4-trifluoro-1-butanone;alpha-Methyl-alpha-hydroxy-gamma,gamma,gamma-trifluoro-4'-(methylsulfonyl)butyrophenone;4,4,4-trifluoro-2-hydroxy-2-methyl-1-(4-methylsulfonylphenyl)butan-1-one
2-(R)-hydroxy-2-methyl-1-(4-(methylsulfonyl)phenyl)-4.4,4-trifluoro-1-butanone化学式
CAS
189956-23-8
化学式
C12H13F3O4S
mdl
——
分子量
310.294
InChiKey
CSCFVJPWMPXALQ-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    1.9
  • 重原子数:
    20
  • 可旋转键数:
    4
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.42
  • 拓扑面积:
    79.8
  • 氢给体数:
    1
  • 氢受体数:
    7

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    2-(R)-hydroxy-2-methyl-1-(4-(methylsulfonyl)phenyl)-4.4,4-trifluoro-1-butanone吡啶1,8-二氮杂双环[5.4.0]十一碳-7-烯 、 silver carbonate 作用下, 以 乙腈 为溶剂, 生成 3-Isopropoxy-4-(4-methanesulfonyl-phenyl)-5-methyl-5-(2,2,2-trifluoro-ethyl)-5H-furan-2-one
    参考文献:
    名称:
    Discovery of a potent and selective COX-2 inhibitor in the alkoxy lactone series with optimized metabolic profile
    摘要:
    The COX-2 inhibitor DFP [5,5-dimethyl-3-(2-propoxy)-4-methanesulfonylphenyl)-2(5H)-furanone] was found to have a long half-life in humans. Analogues have been characterized in order to optimize pharmacokinetics. This has lead to the discovery of 5(S)-(5-ethyl-5-methyl-3-(2-propoxy)-4-methanesulfonylphenyl)-2(5H)-furanone analogue 11 a potent and selective COX-2 inhibitor which is metabolized to a greater extent than DFP upon incubation with rat and human hepatocytes, suggesting a shorter half-life in humans. (C) 2002 Elsevier Science Ltd. All rights reserved.
    DOI:
    10.1016/s0960-894x(02)00739-4
  • 作为产物:
    参考文献:
    名称:
    Discovery of a potent and selective COX-2 inhibitor in the alkoxy lactone series with optimized metabolic profile
    摘要:
    The COX-2 inhibitor DFP [5,5-dimethyl-3-(2-propoxy)-4-methanesulfonylphenyl)-2(5H)-furanone] was found to have a long half-life in humans. Analogues have been characterized in order to optimize pharmacokinetics. This has lead to the discovery of 5(S)-(5-ethyl-5-methyl-3-(2-propoxy)-4-methanesulfonylphenyl)-2(5H)-furanone analogue 11 a potent and selective COX-2 inhibitor which is metabolized to a greater extent than DFP upon incubation with rat and human hepatocytes, suggesting a shorter half-life in humans. (C) 2002 Elsevier Science Ltd. All rights reserved.
    DOI:
    10.1016/s0960-894x(02)00739-4
点击查看最新优质反应信息

文献信息

  • [EN] (METHYLSULFONYL)PHENYL-2-(5H)-FURANONES AS COX-2 INHIBITORS<br/>[FR] (METHYLSULFONYL)PHENYL-2-(5H)-FURANONES EN TANT QU'INHIBITEURS DU COX-2
    申请人:MERCK FROSST CANADA INC.
    公开号:WO1997014691A1
    公开(公告)日:1997-04-24
    (EN) The invention encompasses the novel compound of formula (I) useful in the treatment of cyclooxygenase-2 mediated diseases. The invention also encompasses certain pharmaceutical compositions for treatment of cyclooxygenase-2 mediated diseases comprising compounds of formula (I).(FR) Cette invention, qui porte sur le nouveau composé répondant à la formule (I), composé s'avérant efficace dans le traitement de maladies liées à la cyclo-oxygénase-2, a également trait à certaines compositions pharmaceutiques qui, contenant des composés de ladite formule (I), servent à traiter lesdites maladies.
    该发明涉及一种新的化合物(I)的使用,该化合物可用于治疗环氧合酶-2介导的疾病。该发明还涉及一些药物组合物,用于治疗环氧合酶-2介导的疾病,其中包括化合物(I)。
  • [EN] 3,4-DIARYL-2-HYDROXY-2,5-DIHYDROFURANS AS PRODRUGS TO COX-2 INHIBITORS<br/>[FR] 3,4-DIARYLE-2-HYDROXY-2,5-DIHYDROFURANS UTILISES COMME PROMEDICAMENTS POUR INHIBITEURS DE COX-2
    申请人:MERCK FROSST CANADA INC.
    公开号:WO1997016435A1
    公开(公告)日:1997-05-09
    (EN) The invention encompasses the novel compound of formula (I) useful in the treatment of cyclooxygenase-2 mediated diseases. The invention also encompasses certain pharmaceutical compositions for treatment of cyclooxygenase-2 mediated diseases comprising compounds of formula (I).(FR) L'invention se rapporte à un nouveau composé de la formule (I) utile dans le traitement de pathologies induites par la cyclooxygénase-2. L'invention se rapporte également à certaines compositions pharmaceutiques destinées au traitement de pathologies induites par la cyclooxygénase-2 et comprenant les composés de la formule (I).
    该发明涵盖了式(I)的新型化合物,可用于治疗环氧合酶-2介导的疾病。该发明还涵盖了某些含有式(I)化合物的药物组合物,用于治疗环氧合酶-2介导的疾病。
  • (METHYLSULFONYL)PHENYL-2-(5H)-FURANONES AS COX-2 INHIBITORS
    申请人:MERCK FROSST CANADA INC.
    公开号:EP0863891A1
    公开(公告)日:1998-09-16
  • 3,4-DIARYL-2-HYDROXY-2,5-DIHYDROFURANS AS PRODRUGS TO COX-2 INHIBITORS
    申请人:Merck Frosst Canada & Co.
    公开号:EP0904269B1
    公开(公告)日:2002-01-23
  • US5698584A
    申请人:——
    公开号:US5698584A
    公开(公告)日:1997-12-16
查看更多